Georgi received his Ph.D. in Mathematics from Vanderbilt University in 2012, developing an age-structured model of cancer cell proliferation and mutation acquisition. He did Visiting Assistant Professorships at Purdue and the University of Iowa, teaching Math and expanding his Mathematical Biology portfolio of projects, techniques, and areas. In 2017 he joined Pfizer Inc. as a modeler in their biologics preclinical translational modeling group. There he used mechanistic systems biology models to advise the discovery teams on target feasibility, lead development, and candidate selection. He also assisted the clinical pharmacology teams with efficacious and starting dose projections. His work in industry has spanned several disease areas and modalities, focusing on indications in inflammation and immunology.
Georgi has been passionate about Mathematical Biology for over a decade. Despite having the nerd in him tickled by elegant mathematical descriptions of complex biology, he focuses on developing fit-for-purpose models that address immediate problems and drive major scientific and business decisions.
Key Research
- A next generation mathematical model for the in vitro to clinical translation of T-cell engagers